NRO Neurones SA

Neurones: 2021 first half-year net profit stands at 7.2%

Neurones: 2021 first half-year net profit stands at 7.2%

PRESS INFORMATION

Heading: First half 2021 results        Nanterre, September 8, 2021 (after trading)

2021 first half-year net profit stands at 7.2%

Account at June 30 (audited in € millions)H1 20202020H1 2021
Revenues254.4524.5289.3
Business operating profit *22.8 (9%)*53.9 (10.3%)*31.1 (10.8%)*
Operating profit22.1 (8.7%)51.9 (9.9%)30.3 (10.5%)
Net financial profit1.41.70
Income tax(8.4)(18.6)(9.4)
Net profit after tax15.1 (5.9%)35 (6.7%)20.9 (7.2%)
of which, group share13.530.918.3
Staff at end of period5,4525,5895,704

* before cost of bonus shares

Achievements

After audit, operating profit for the half-year was confirmed at 10.5% of revenues, compared with 8.7% for the same period last year.

At €20.9 million, net profit for the first half represented 7.2% of revenues. The reduction in the corporate income tax rate in France, combined with the reduction in the CVAE (Company Value Added Contribution), resulted in a reduction of nearly 5 percentage points in the income tax rate.

Even after the payment of an exceptional dividend of €48.4 million, net cash (excluding IFRS 16 rental liabilities) stands at €231.4 million, compared with €228.9 million at June 30, 2020.

Outlook

In a previous press release (1st half revenues), NEURONES raised its forecasts for 2021:

  • revenues of at least €570 million,
  • operating profit close to 10%.

These forecasts may be adjusted on November 3, when the third quarter revenues will be published.

About NEURONES

With 5,700 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 – DSS mid caps

Press Relations:

O'Connection

Valérie Hackenheimer

Tel.: +33 (0)6 12 80 35 20







NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

Attachment



EN
08/09/2021

Underlying

NRONeurones SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

NEURONES: Organic growth up 5.3% in 2nd quarter 2025 PRESS INFORMATION        Nanterre, August 6, 2025 (after trading)Heading: 1st half 2025 revenues Organic growth up 5.3% in 2nd quarter 2025 Revenues (millions of euros)20242025Growthof which organicQ1204.9214.1+ 4.5%+ 3.9%Q2197.5210.2+ 6.4%+ 5.3%Total H1 revenues402.4424.3+ 5.4%+ 4.6% Achievements Organic growth of 5.3% in the second quarter was achieved in a more challenging economic environment. The most notable growth was in Data, Digital projects, market finance, ITSM (Service Now) solutions, and Business Process Management, with t...

August 6, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025 INFORMATION PRESSE        Nanterre, le 6 août 2025 (après Bourse)Rubrique : C.A. 1er semestre 2025 + 5,3% de croissance organique au 2e trimestre 2025 C.A. (en millions d’euros)20242025Croissancedont organique1er trimestre204,9214,1+ 4,5%+ 3,9%2e trimestre197,5210,2+ 6,4%+ 5,3%Total 1er semestre402,4424,3+ 5,4%+ 4,6% Réalisations A 5,3%, la croissance organique du deuxième trimestre a été réalisée dans des conditions économiques plus tendues. Les progressions les plus notables concernent la Data, les projets Digitaux, la fina...

August 6, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : Descriptif du programme de rachat d'actions

NEURONES : Descriptif du programme de rachat d'actions INFORMATION PRESSERubrique : Rachat d’actions                                         Nanterre, le jeudi 5 juin 2025 (après Bourse) DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS L’Assemblée Générale des actionnaires du 5 juin 2025 a renouvelé l’autorisation consentie au Conseil d’administration, pour une durée de 18 mois, de procéder à l’achat des propres actions de la société. Etabli en application de l’article 241-2 et suivants du Règlement général de l’AMF, le présent descriptif précise les modalités et les objectifs du programme d...

June 5, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025 PRESS INFORMATIONHeading: 1st quarter revenues 2025        Nanterre, May 7, 2025 (after trading) 3.9% increase in organic growth in the 1st quarter of 2025 (in millions of euros)Q1 2024Q1 2025Growthof which organicRevenues204.9214.1+ 4.5%+ 3.9% Achievements Driven by its cloud, digital and data activities, the Group's organic growth increased by 3.9% over the first three months of the year. Operating profit (*) totaled 8.2% of revenues. The increase in taxation (the fixed social security charge on bonus shares rose...

May 7, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : + 3,9% de croissance organique au 1er trimestre 2025

NEURONES : + 3,9% de croissance organique au 1er trimestre 2025 INFORMATION PRESSERubrique : C.A. 1er trimestre 2025        Nanterre, le 7 mai 2025 (après Bourse) + 3,9% de croissance organique au 1er trimestre 2025 (en millions d’euros)T1 2024T1 2025Croissancedont organiqueChiffre d’affaires204,9214,1+ 4,5%+ 3,9% Réalisations Soutenue par le cloud, le digital et la data, la croissance organique du groupe s’établit à + 3,9% sur les trois premiers mois de l’année. Le résultat opérationnel (*) s’élève à 8,2% du chiffre d’affaires. La fiscalité en hausse (passage de 20 à 30% du forfait soci...

May 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch